dalfampridine 10 MG 12HR Extended Release Oral Tablet
- RxCUI
- 897021
- RxNorm name
- dalfampridine 10 MG 12HR Extended Release Oral Tablet
- Display name
- dalfampridine 10 MG 12HR Extended Release Oral Tablet
- Full name
- dalfampridine 10 MG 12HR Extended Release Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:18
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dalfampridine | DALFAMPRIDINE | Ascend Laboratories, LLC | e10b2d92-2824-4395-8883-6fd52c784aa4 | 2026-07-14 | Warnings, Adverse reactions | 897021 |
| AMPYRA | DALFAMPRIDINE | Merz Pharmaceuticals, LLC | 550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783 | 2026-01-16 | Warnings, Adverse reactions | 897021 |
| Dalfampridine | DALFAMPRIDINE | Accord Healthcare Inc. | 354a97e8-35c8-418b-91b2-9e8e066cec65 | 2025-10-09 | Warnings, Adverse reactions | 897021 |
| DALFAMPRIDINE | DALFAMPRIDINE | Micro Labs Limited | 302c8270-4711-4ca4-bee8-be0738fbe094 | 2025-07-28 | Warnings, Adverse reactions | 897021 |
| Dalfampridine | DALFAMPRIDINE | CivicaScript LLC | c40dcc84-b839-44aa-94f2-886fb1c3d75c | 2025-07-16 | Warnings, Adverse reactions | 897021 |
| AMPYRA | DALFAMPRIDINE | Merz Pharmaceuticals, LLC | 974fb2af-7012-4989-b330-e44a31c9c3e5 | 2025-05-05 | Warnings, Adverse reactions | 897021 |
| DALFAMPRIDINE | DALFAMPRIDINE | Bryant Ranch Prepack | 688eb479-debc-4cfc-a74d-14828c347049 | 2025-02-12 | Warnings, Adverse reactions | 897021 |
| DALFAMPRIDINE | DALFAMPRIDINE | Aurobindo Pharma Limited | 43996322-7d83-4420-9e61-4ed37f710fee | 2024-02-15 | Warnings, Adverse reactions | 897021 |
| Dalfampridine | DALFAMPRIDINE | Golden State Medical Supply, Inc. | 1134ac0f-59c1-a20b-e063-6294a90affcc | 2024-02-12 | Warnings, Adverse reactions | 897021 |
| Dalfampridine | DALFAMPRIDINE | Sun Pharmaceutical Industries, Inc. | d61e15fa-0334-49a0-ab41-c9a36b726b57 | 2023-10-16 | Warnings, Adverse reactions | 897021 |
| Dalfampridine | DALFAMPRIDINE | Actavis Pharma, Inc. | ed826777-b8c4-4d35-aa64-a4c28452baa8 | 2021-12-02 | Warnings, Adverse reactions | 897021 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b9ad68e2-a515-4dba-915d-401c555a8a26 | dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY] | 3 | 101 | These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DALFAMPRIDINE EXTENDED-RELEASE TABLETS. DALFAMPRIDINE extended-release tablets, for oral use Initial U.S. Approval: 2010 | 20230316 |
| 688eb479-debc-4cfc-a74d-14828c347049 | dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY] | 3 | 100 | These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DALFAMPRIDINE EXTENDED-RELEASE TABLETS. DALFAMPRIDINE extended-release tablets, for oral use Initial U.S. Approval: 2010 | 20250212 |
| 550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783 | dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY] | 3 | 22 | These highlights do not include all the information needed to use AMPYRA safely and effectively. See full prescribing information for AMPYRA. AMPYRA ® (dalfampridine) extended-release tablets, for oral use Initial U.S. Approval: 2010 | 20260116 |
| e10b2d92-2824-4395-8883-6fd52c784aa4 | dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY] | 3 | 12 | These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DALFAMPRIDINE EXTENDED-RELEASE TABLETS. DALFAMPRIDINE extended-release tablets, for oral use Initial U.S. Approval: 2010 | 20230130 |
| 302c8270-4711-4ca4-bee8-be0738fbe094 | dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY] | 3 | 9 | These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DALFAMPRIDINE EXTENDED-RELEASE TABLETS. DALFAMPRIDINE extended-release tablets, for oral use Initial U.S. Approval: 2010 | 20250728 |
| ed826777-b8c4-4d35-aa64-a4c28452baa8 | dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY] | 3 | 9 | These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DALFAMPRIDINE EXTENDED-RELEASE TABLETS. DALFAMPRIDINE extended-release tablets, for oral use Initial U.S. Approval: 2010 | 20211202 |
| 354a97e8-35c8-418b-91b2-9e8e066cec65 | dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY] | 3 | 8 | These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DALFAMPRIDINE EXTENDED-RELEASE TABLETS. DALFAMPRIDINE extended-release tablets, for oral use Initial U.S. Approval: 2010 | 20251009 |
| d61e15fa-0334-49a0-ab41-c9a36b726b57 | dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY] | 3 | 7 | These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DALFAMPRIDINE EXTENDED-RELEASE TABLETS. DALFAMPRIDINE extended-release tablets, for oral use Initial U.S. Approval: 2010 | 20231016 |
| 43996322-7d83-4420-9e61-4ed37f710fee | dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY] | 3 | 6 | These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DALFAMPRIDINE EXTENDED-RELEASE TABLETS. DALFAMPRIDINE extended-release tablets, for oral use Initial U.S. Approval: 2010 | 20240215 |
| c40dcc84-b839-44aa-94f2-886fb1c3d75c | dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DALFAMPRIDINE EXTENDED-RELEASE TABLETS. DALFAMPRIDINE extended-release tablets, for oral use Initial U.S. Approval: 2010 | 20250716 |
| 974fb2af-7012-4989-b330-e44a31c9c3e5 | dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use AMPYRA safely and effectively. See full prescribing information for AMPYRA. AMPYRA ® (dalfampridine) extended-release tablets, for oral use Initial U.S. Approval: 2010 | 20250505 |
| 1134ac0f-59c1-a20b-e063-6294a90affcc | dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY] | 3 | 1 | DALFAMPRIDINE EXTENDED-RELEASE TABLETS. These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DALFAMPRIDINE EXTENDED-RELEASE TABLETS. DALFAMPRIDINE extended-release tablets, for oral use Initial U.S. Approval: 2010 | 20240212 |